Search for: "ACCESS THERAPIES, INC" Results 81 - 100 of 270
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Aug 2012, 10:00 am by Lucas A. Ferrara, Esq.
Marqibo is marketed by Talon Therapeutics Inc., based in South San Francisco, Calif. [read post]
14 Oct 2014, 5:30 am by Guest Blogger
  Greater Baltimore Center for Pregnancy Concerns, Inc. v. [read post]
19 Dec 2011, 1:38 pm by Antoinette Konski
Prometheus Laboratories, Inc., (reported in our December 7th post) the American Civil Liberties Union Foundation (“ACLU”) and the Public Patent Foundation petitioned the U.S. [read post]
21 Jun 2010, 2:30 pm by Lucas A. Ferrara, Esq.
Patients who are currently receiving the drug may complete their therapy following consultation with their health care professional. [read post]
5 Sep 2023, 4:02 am by Guest Contributor
As employers, we should be designing our health plans to foster affordable access and adherence to therapies. [read post]
7 Feb 2017, 1:20 pm by Tom Lamb
Most disease-modifying treatments for MS, including all approved oral therapies, have labeling reflecting a risk of hepatic injury. [read post]
13 Jan 2011, 10:49 am by StephanieWestAllen
”Research studyIn 2010, 239 Aetna employees who volunteered to participate in a mind-body stress reduction program had access to a pilot that offered complementary therapies focused on mindfulness meditation and yoga. [read post]
7 Feb 2013, 2:54 pm by Ken
He has litigated cases against Intel Corporation, Toyota Motor Sales, USA, Inc., Honda North America, Inc., Aston Martin Lagonda of North America, Inc., BMW of North America, LLC, Mercedes-Benz USA, LLC, Keyes European, LLC, Rusnak Enterprises, LLC and Wells Fargo Auto Finance, Inc. [read post]
18 Jan 2018, 9:34 am by m zamora
WARNING LETTERMark BaumImprimis Pharmaceuticals Inc.12264 El Camino Real, Suite 350San Diego, CA 92130Dear Mr. [read post]
6 Apr 2020, 9:05 pm by A. Rahman Ford
A victory for Lander and Berman could have broad implications for immediate patient access to stem cell therapy and could mark the beginning of a potential further loosening of FDA stem cell restrictions. [read post]